Home
Who We Are
Who We Are
Testimonials
Collaborations
Consulting
Inspection Readiness
GxP Auditing
Quality Systems
Quality Risk Management
Monitoring Services
Training
GCP Training Services
Training Courses
DIGR-ACT
DIGR-ACT - Home
DIGR-ACT - About
DIGR-ACT - Contact Us
Online Store
Catalog
Blog
Contact

Clinical Pathways

Home
Who We Are
Who We Are
Testimonials
Collaborations
Consulting
Inspection Readiness
GxP Auditing
Quality Systems
Quality Risk Management
Monitoring Services
Training
GCP Training Services
Training Courses
DIGR-ACT
DIGR-ACT - Home
DIGR-ACT - About
DIGR-ACT - Contact Us
Online Store
Catalog
Blog
Contact
August 11, 2026
Guest User
Annex 2 of ICH E6(R3) Reaches Step Four

08/11/2026

-

On June 3rd, 2026, the International Council of Harmonisation’s final ICH Guideline for Good Clinical Practice (GCP) E6(R3) Annex 2 was adopted in step 4 of the ICH formal procedure. A reminder of ICH’s standardized five-step formal procedure of developing, adopting, and implementing of guidelines can be reviewed. 

Annex 2 of ICH E6(R3) Reaches Step Four
July 23, 2026
Guest User
New Draft Guidance – Responding to FDA Form 483s

07/23/2026

-

On March 9th, 2026, the US Food and Drug Administration (FDA) released a draft guidance “Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection”. The guidance is intended to assist drug manufacturers of FDA regulated drugs or combination products who choose to respond to an FDA Form 483 Inspectional Observations (483).

New Draft Guidance – Responding to FDA Form 483s
June 8, 2026
Guest User
Update - ISO 14155 Device GCP 2026 and Clinical ...

06/07/2026

-

In March 2026, the International Organization for Standardization (ISO) published the fourth edition of ISO 14155:2026, replacing the previous edition from 2020. This is the medical device global reference for GCP conduct that many regulatory authorities recognize. Clinical Pathways offers an ISO 14155 Comparison Tool to support you to do an impact analysis and plan updates to SOPs, templates and tools for your trials.

Update - ISO 14155 Device GCP 2026 and Clinical Pathway’s New eLearning & Comparison Tool
May 26, 2026
Guest User
Get Ready for AI Assisted FDA Inspections Part ...

05/26/2026

-

The US Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) collaborated with the European Medicines Agency (EMA) to develop 10 Guiding Principles of Good AI Practice in Drug Development. They are intended to be a foundational basis for developing good practices with AI, addressing the unique nature of AI, as well as cultivating its future growth.

Get Ready for AI Assisted FDA Inspections Part 3/3
April 30, 2026
Guest User
Get Ready for AI Assisted FDA Inspections Part ...

04/30/2026

-

In addition to the launch of Elsa, in a press announcement on December 1, 2025, the FDA broadcasted the deployment of Agentic AI capabilities for their employees. Agentic AI is unique from LLM AI due to its capability to plan, reason, and execute multi-step actions in order to achieve a specific goal. This means it can be used to assist with more complex tasks.

Get Ready for AI Assisted FDA Inspections Part 2/3
Sandra Sather
December 9, 2014

Just Released: OHRP 2015 Edition of the International Compilation of Human Research Standards

Sandra Sather
December 9, 2014

12/09/2014

The OHRP 2015 edition of the International Compilation of Human Research Standards has just been released. View it here and learn more on what was discussed!

Sandra Sather
December 9, 2014

RBM Workshop live: Less than Two Weeks Away!

Sandra Sather
December 9, 2014

12/09/2014

I will be presenting a 1/2 day workshop. Ring in the New Year!

Sandra Sather
November 16, 2014

New Draft Guidance from OHRP: Disclosing Reasonably Foreseeable Risks in Research Evaluating Standards of Care

Sandra Sather
November 16, 2014

11/16/2014

On October 20th, the Office for Human Research Protections’ (OHRP’s) released a new draft guidance which when finalized, will represent their current thinking on this topic.

Sandra Sather
October 13, 2014

Follow-up: Site Solution Summit Master Workshops and Conference

Sandra Sather
October 13, 2014

10/13/14

The Site Solution Summit was another example of great collaborations increasing between Sites, IRBs, Sponsors and CROs!  We are in an exciting era for clinical trials. Like we heard in the FDA presentation, clinical "trails".  

Sandra Sather
September 22, 2014

CRA Oversight

Sandra Sather
September 22, 2014

09/22/2014

Using a “risk-based” approach has paid big dividends in clinical trials, as its principles are applicable to many different functional areas. This is no more visible than when applied to the oversight of Clinical Research Associates (CRA).

Older Posts
 
Archive List
  • 2013 6
  • 2014 31
  • 2015 25
  • 2016 21
  • 2017 31
  • 2018 55
  • 2019 56
  • 2020 63
  • 2021 50
  • 2022 39
  • 2023 27
  • 2024 25
  • 2025 31
  • 2026 9

No results found

Subscribe to Blogs and Newsletters.

By signing up, you agree to our our Privacy Policy. You may unsubscribe from emails at any time.

Thank you! You will receive a confirmation email shortly.

Back to Top
Clinical Pathwaysinfo@clinicalpathwaysresearch.com

Cookie Notice | License Agreement | Privacy Policy | Return Policy | Terms and Conditions | Data Security Policy | Confidentiality Policy

© 2026 Clinical Pathways. All rights reserved.